Glycans in Vaccine Development

Glycans are at the center of many disorders and diseases sparking the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycans are intricately involved. Gaging the vast potential and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.

  • Glycoconjugate vaccines
  • Glycoengineering of immunogens
  • Biomarkers in drug design
  • Screening and drug design
  • Drug interaction in cellular networking
  • Biodefense vaccine mechanism

Related Conference of Glycans in Vaccine Development

February 12-13, 2018

Glycobiology Biochem Conference 2018

Paris, France
September 17-18, 2018

34th International Conference on Chemical Biology & Radiation Therapy

San Diego, California
August 27-28, 2018

5th International Conference on Glycobiology

Toronto, Canada
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
November 29-30, 2018

12thInternational Conference on Bioinformatics

Dublin, Ireland

Glycans in Vaccine Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in